Antibodies should only be measured in participants in clinical trials when the result can form the basis for the conclusions of those studies, Protsenko said. At the same time, a fashion has developed in
Russia to “measure antibodies,” he believes. Antibodies for
COVID-19 need to be measured only by participants in clinical trials when this measurement is necessary for analysis, Denis Protsenko, h...